Clinical Trial Update: Quality of Life in Multiple Myeloma Patients Treated With Bortezomib

View source ↗

Summary

A completed clinical trial update examining quality of life in multiple myeloma patients treated with bortezomib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Multiple Myeloma | Status: COMPLETED